These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26396046)

  • 1. Detecting Prostate Cancer.
    Brock M; von Bodman C; Palisaar J; Becker W; Martin-Seidel P; Noldus J
    Dtsch Arztebl Int; 2015 Sep; 112(37):605-11. PubMed ID: 26396046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiparametric MRI and MRI-TRUS fusion biopsy in patients with prior negative prostate biopsy].
    Kesch C; Radtke JP; Distler F; Boxler S; Klein T; Hüttenbrink C; Hees K; Roth W; Roethke M; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Urologe A; 2016 Aug; 55(8):1071-7. PubMed ID: 27168038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.
    Baco E; Rud E; Eri LM; Moen G; Vlatkovic L; Svindland A; Eggesbø HB; Ukimura O
    Eur Urol; 2016 Jan; 69(1):149-56. PubMed ID: 25862143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
    Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
    J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
    Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
    Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of perineal HistoScanning™ template-guided prostate biopsy].
    Hamann MF; Hamann C; Olzem D; Trettel A; Juenemann KP; Naumann CM
    Urologe A; 2015 Nov; 54(11):1596, 1598-601. PubMed ID: 25794587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of prostate cancer by real-time MR/ultrasound fusion-guided biopsy: 3T MRI and state of the art sonography].
    Durmus T; Stephan C; Grigoryev M; Diederichs G; Saleh M; Slowinski T; Maxeiner A; Thomas A; Fischer T
    Rofo; 2013 May; 185(5):428-33. PubMed ID: 23420313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy.
    Cool DW; Zhang X; Romagnoli C; Izawa JI; Romano WM; Fenster A
    AJR Am J Roentgenol; 2015 Jan; 204(1):83-91. PubMed ID: 25539241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
    Schoots IG; Roobol MJ; Nieboer D; Bangma CH; Steyerberg EW; Hunink MG
    Eur Urol; 2015 Sep; 68(3):438-50. PubMed ID: 25480312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies.
    Kaufmann S; Kruck S; Kramer U; Gatidis S; Stenzl A; Roethke M; Scharpf M; Schilling D
    Urol Int; 2015; 94(3):319-25. PubMed ID: 25227711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.
    Siddiqui MM; George AK; Rubin R; Rais-Bahrami S; Parnes HL; Merino MJ; Simon RM; Turkbey B; Choyke PL; Wood BJ; Pinto PA
    J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27130933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
    Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Detection Rates in Targeted Transperineal MRI-TRUS Elastic Fusion-guided Prostate Biopsies Performed Under Local Anesthesia.
    Jacewicz M; Rud E; Galtung KF; Noor D; Baco E
    Anticancer Res; 2021 Sep; 41(9):4395-4400. PubMed ID: 34475059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MRI navigated stereotactic prostate biopsy: fusion of MRI and real-time transrectal ultrasound images for perineal prostate biopsies].
    Kuru TH; Tulea C; Simpfendörfer T; Popeneciu V; Roethke M; Hadaschik BA; Hohenfellner M
    Urologe A; 2012 Jan; 51(1):50-6. PubMed ID: 21935634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.
    Arsov C; Quentin M; Rabenalt R; Antoch G; Albers P; Blondin D
    Anticancer Res; 2012 Mar; 32(3):1087-92. PubMed ID: 22399637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.